Načítá se...
Cyclopeptide COR-1 to treat beta1-adrenergic receptor antibody-induced heart failure
RATIONALE: Despite advances in pharmacotherapy, heart failure still incurs significant morbidity and mortality. Stimulating antibodies directed against the secondextracellular loop of the human ß(1)-adrenergic receptor (anti-ß(1)EC2) cause myocyte damage and heart failure in rats. This receptor doma...
Uloženo v:
| Vydáno v: | PLoS One |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Public Library of Science
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6101361/ https://ncbi.nlm.nih.gov/pubmed/30125285 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0201160 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|